EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MAIA Biotechnology's enterprise value is $43.08 Mil.
MAIA Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, MAIA Biotechnology's EV-to-Revenue for today is .
The historical rank and industry rank for MAIA Biotechnology's EV-to-Revenue or its related term are showing as below:
MAIA's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 7.47 * Ranked among companies with meaningful EV-to-Revenue only.
The historical data trend for MAIA Biotechnology's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MAIA Biotechnology's EV-to-Revenue
For the Biotechnology subindustry, MAIA Biotechnology's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MAIA Biotechnology's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MAIA Biotechnology's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where MAIA Biotechnology's EV-to-Revenue falls into.
MAIA Biotechnology's current Enterprise Value is $43.08 Mil.
MAIA Biotechnology's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAIA Biotechnology's share price for today is $1.79.
MAIA Biotechnology's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAIA Biotechnology EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of MAIA Biotechnology's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MAIA has been successfully added to your 